Date:- September 28 - 29 2022
Location:- Boston
Veracyte’s Biopharma team will be glad to meet you at World CB and CDx meeting in Boston, to discuss your clinical programs and introduce our customized biomarker testing and analytical services leveraging our novel insights into the molecular underpinnings of disease and our expertise in immuno-oncology.
Veracyte also offers a complete range of in vitro diagnostic and companion diagnostic development services to biopharmaceutical and diagnostic companies.
Join our talk “Co-development of biomarkers from the tumor micro-environment, from early phase clinical trials to successful CDx commercialization” presented by Naouel El Asri, Senior Director, Pharma Services at Veracyte, Thursday, September 29, 2022 at 8.55AM EDT
If you are not attending, contact us to receive the presentation after the talk.